亿胜生物科技（股票代码：01061）于2026年8月19日发布翌日披露报表，公告显示公司当日于香港联交所回购普通股20,000股，占回购前已发行股本0.00354%。本次回购每股价格为2.3港元，合计耗资46,000港元。
回购完成后，公司已发行股本（不包括库藏股）变更为565,180,000股，库藏股数量为1,826,000股，合计已发行股份总数仍为567,006,000股。据公告，购回授权于2026年5月26日获通过，授权可回购股数为56,700,600股，截至目前公司已累计回购1,826,000股，占购回授权通过当日已发行股本的0.32204%。
公司确认已遵守香港联交所上市规则及相关法例的规定。本公告由公司董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.